Advisory Alpha’s DexCom DXCM Stock Holding History

Advisory Alpha’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,704	Closed	-$236K	–	525
2025 Q2	$236K	Buy	+2,704	New	+$212K	0.01%	431
2025 Q1	–	Sell	-2,642	Closed	-$205K	–	459
2024 Q4	$205K	Buy	+2,642	New	+$196K	0.01%	423
2020 Q4	–	Sell	-12	Closed	-$1K	–	239
2020 Q3	$1K	Buy	+12	New	+$1.25K	﹤0.01%	645
2020 Q2	–	Sell	-12	Closed	-$966	–	215
2020 Q1	$966	Sell	12 -12	-50%	-$747	﹤0.01%	643
2019 Q4	$1.42K	Hold	24	–	–	﹤0.01%	675
2019 Q3	$923	Buy	+24	New	+$932	﹤0.01%	745
2019 Q2	–	Sell	-24	Closed	-$703	–	247
2019 Q1	$703	Buy	+24	New	+$843	﹤0.01%	619

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Advisory Alpha's DXCM Position: Q3 2025 in Review

Advisory Alpha sold out of DexCom (DXCM) in Q3 2025, closing a stake of 2,704 shares — an estimated $236K sold.

Advisory Alpha first reported a position in DXCM in Q1 2019 and held it in 7 quarters. The position peaked at $236K in Q2 2025. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

Advisory Alpha reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
Advisory Alpha sold 2,704 DexCom shares in Q3 2025, an estimated $236K.
Advisory Alpha first reported a position in DexCom in Q1 2019 and held it in 7 quarters.
Advisory Alpha's DexCom position peaked at $236K in Q2 2025.
911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Advisory Alpha's 13F filing for Q3 2025, filed 12 Nov 2025.